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Abstract Angiogenesis after ischemic brain injury contrib-
utes to the restoration of blood supply in the ischemic zone.
Strategies to improve angiogenesis may facilitate the function
recovery after stroke. Recent researches have demonstrated
that dysfunction of long non-coding RNAs are associated with
angiogenesis. We have previously reported that long non-
coding RNAs (lncRNAs) are aberrantly expressed in ischemic
stroke. However, little is known about long non-coding RNAs
and theirs role in angiogenesis after stroke. In this study, we
identified a rat lncRNAs, Meg3, and found that Meg3 was
significantly decreased after ischemic stroke. Overexpression
of Meg3 suppressed functional recovery and decreased capil-
lary density after ischemic stroke. Downregulation of Meg3
ameliorated brain lesion and increased angiogenesis after is-
chemic stroke. Silencing of Meg3 resulted in a proangiogenic
effect evidenced by increased endothelial cell migration, pro-
liferation, sprouting, and tube formation. Mechanistically, we
showed that Meg3 negatively regulated notch pathway both
in vivo and in vitro. Inhibition of notch signaling in endothe-
lial cells reversed the proangiogenic effect induced by Meg3
downregulation. This study revealed the function of Meg3 in
ischemic stroke and elucidated its mechanism in angiogenesis
after ischemic stroke.
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Introduction
Stroke is a leading cause of long-term disability in high-
income countries and a leading cause of death worldwide.
Each year, ∼795,000 people experience a new or recurrent
stroke, and 87% of the strokes are ischemic [1]. So far, effec-
tive stroke treatments remain limited despite the marked im-
provements that have been achieved in medical and
endovascular recanalization therapy. Recent studies have
shown that angiogenesis is activated after stroke, and that
higher microvessel density is associated with less morbidity
and longer survival [2]. Clinically, angiogenesis has important
implications because induction of angiogenesis after ischemic
stroke stimulates endogenous recovery mechanisms, which
promote neurogenesis and increase neuronal and synaptic
plasticity and therefore improve the neurological outcome
[3]. Hence, proangiogenesis may represent a promising ther-
apeutic strategy which requires more innovative elaborating
for patients with ischemic stroke.
Angiogenesis after stroke is a well-orchestrated sequence
of complex biological and molecular events which is precisely
regulated by proangiogenic and antiangiogenic factors such as
VEGF, BDNF, and bFGF [4]. Long non-coding RNAs
(lncRNAs), which constitute a significant portion of the
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mammalian genome, have emerged as key regulators impli-
cated in angiogenesis [5]. Avery recent study has demonstrat-
ed that the lncRNA,MALAT1, regulates endothelial cell func-
tion and promotes neovascularization after hind-limb ische-
mia [6]. We have previously demonstrated that lncRNAs are
aberrantly expressed in ischemic stroke and involved in the
pathophysiology of stroke (GSE78200). However, whether
lncRNAs are involved in the regulation of angiogenesis after
ischemic stroke remains poorly defined.
To address this issue, we analyzed our RNA-Seq datasets
and identified a novel rat lncRNA which was human and
mouse maternally expressed gene 3 (Meg3) ortholog. Meg3,
also known as gene trap locus 2 (Gtl2) in mouse, encodes a
long non-coding RNA which is widely expressed in many
tissues and cells, such as brain and endothelial cells [6, 7].
Growing evidences suggest that Meg3 is a tumor suppressor
lncRNA and its expression is lost in many tumors and cancer
cell lines [8–11]. Overexpression of Meg3 has been shown to
suppress tumor cell growth and promote cell apoptosis in vitro
[12, 13]. Moreover, inactivation ofMeg3 leads to a significant
increase in expression of notch pathway genes and
microvessel density in the brain of Meg3 knockout mice
[14]. Notch signaling is an evolutionarily well-conserved
pathway that plays a crucial role in the regulation of angio-
genesis [15, 16]. Several members of the Notch family are
specifically expressed in endothelial cells [17, 18]. In particu-
lar, mouse embryos lacking endothelial Notch1 show defects
in angiogenesis and vascular development [19]. We and other
groups have previously shown that notch signaling is activat-
ed after ischemic stroke and the upregulated notch promotes
angiogenesis in the ischemia brain tissue [20, 21]. Thus, we
presently evaluated whether Meg3 is involved in angiogenesis
after ischemic stroke and, if yes, if its mechanism of action is
by modulating the notch signaling.
Materials and Methods
Bioinformatic Analysis
RNA-Sequencing data (GSE78200) was downloaded from
Gene Expression Omnibus which included five pairs of rat
brain samples. Raw reads were cleaned by removing adap-
tors and low quality reads before assembly. Reads from the
FASTQ files were mapped to the rat genome (RGSC 5.0/
rn5) and splice junctions were identified by TopHat. The
output files were analyzed by Cufflinks to estimate the
transcript abundances. Cufflinks generated transcript struc-
ture predictions were then compared to the reference anno-
tation Ensembl GTF by Cuffcompare. The gene expression
level was expressed in fragments per kilobase of exon per
million reads mapped (FPKM) and calculated by the
TopHat and Cufflinks package. BLASTN analysis of the
putative lncRNAs was used to identify the homologous
genes.
RACE and Generation of Full-Length MEG3 Sequence
To determine the transcriptional initiation and termination
sites of rat MEG3, 5′ and 3′ rapid amplification of cDNA
end (RACE) analyses were performed with 5′-full RACE
and 3′-full RACE Core Set kits (Takara Bio, Japan) according
to the manufacturer’s instructions. The gene-specific primers
(GSPs) used for the PCR of the RACE analysis were as fol-
lows: 5′ RACEMEG3 outer GSP: 5′-TGATGAACACGAGC
ACAGATG-3′ and 5′ RACE MEG3 inner GSP: 5′-GGGG
GTCCACAAGAAGTTG-3′; 3′ RACE MEG3 GSP: 5′-
CCCCTTGAGTAGAGAGACCCA-3′; products were cloned
into pMD19-T vectors (Takara Bio, Japan) and then se-
quenced. The full length of rat MEG3 was cloned by 5′- and
3′-RACE and the PCR primers were as follows: forward, 5′-
AGAAGGCGAAGAACTGGAATAGAG-3′ and reverse, 5′-
AGTTAAAACAAGAAACATTTATTGAAAGCAC-3′.
Products were cloned and then sequenced.
Animals
All animal procedures were approved by the ethics Committee
of Shanghai Jiao Tong University and performed according to
the guidelines of the USDepartment of Health for use and care
of laboratory animals. A total of 268 adult male Sprague–
Dawley rats (weight 240–250 g) were included in the study.
Data are reported on 160 animals. One hundred eight animals
were excluded from the study due to no neurologic abnormal-
ities (30) or death (78). The rats were randomly assigned to 4
groups: control group (rats underwent control lentivirus injec-
tion), Meg3 group (rats underwent Meg3 lentivirus injection),
sh-Ctrl group (rats underwent sh-Ctrl lentivirus injection), and
sh-Meg3 group (rats underwent sh-Meg3 lentivirus injection).
The animal experimental design is illustrated in Fig. 2a.
Construction of Lentiviral and Stereotactic Injection
The cloned Meg3 was inserted in the lentiviral expression
vector pCDH-CMV-MCS-EF1-copRFP (System Biosciences
SBI, CA, USA) located downstream of the cytomegalovirus
promoter. An empty pCDH vector was used as control. sh-
Meg3 which specifically targeted Meg3 was inserted into
pGLV10/U6/RFP/Puro vector (GenePharma, Shanghai,
China), and a scramble sequence was used as negative sh-
Ctrl. Stereotactic injection was performed as described previ-
ously [22]. In brief, rats were placed in a stereotactic frame
(World Precision Instruments Inc., China) under anesthesia,
with reference to Paxinos andWatson’s Rat Brain map. A total
volume of 10 μL of viral suspension containing 1 × 109 con-
trol, Meg3, sh-Ctrl, or sh-Meg3 particles was slowly injected
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into the striatum (bregma; 0.8 mm posterior, 3 mm dorsoven-
tral, 4.5 mm lateral). The needle was left in place for an addi-
tional 5 min and then gently withdrawn. The bone hole was
sealed, the wound was sutured, and the animals were returned
to their cages after awake.
MCAOModel
Transient middle cerebral artery occlusion (MCAO) model
in rat was performed as described previously [23]. Briefly,
3 days after injection, the rats were anesthetized with 4%
isoflurane in 70% N2O/30% O2 using a mask. A 4-0 nylon
suture with silicon was inserted into the internal carotid
artery and gently advanced to occlude the middle cerebral
artery (MCA). The body temperature was carefully moni-
tored during the surgery and maintained at 37.0 ± 0.5 °C
using a heating pad. After 2 h of MCA occlusion (MCAO),
the suture was carefully removed to restore blood flow, and
rats score <1 according to Zea-Longa five-point scale (0,
no deficit; 1, failure to extend right paw; 2, circling to the
right; 3, falling to the right; and 4, unable to walk sponta-
neously) were excluded from the study.
TTC Staining and Evaluation of Infarction Volume
Brains were sliced into 2 mm thick coronal sections in
an adult rat brain matrix (World Precision Instruments
Inc., Shanghai, China) 7 days after MCAO. The slices
were stained in 2% 2, 3, 5-triphenyltetrazolium chloride
(TTC) (Sigma, St, Louis, USA) for 30 min at 37 °C in
the dark. Sections were imaged and digitized, and the
border between infarct and non-infarct tissue was
outlined using ImageJ. Infarct volume was calculated
by subtracting the volume of intact area in the ipsilateral
hemisphere from the whole volume of the contralateral
hemisphere.
Neurobehavioral Tests
Neurobehavioral deficits were determined by modified
neurologic severity score (mNSS) and adhesive-removal
somatosensory test before MCAO and at 7, 14, and
28 days after MCAO by an investigator blinded to the
treatments.
For modified neurological severity scores, neurological
function was graded on a scale of 0 to 18 (normal score, 0;
maximal deficit score, 18). mNSS is a composite of motor,
sensory, reflex, and balance tests. In the severity scores of
injury, 1 score point is awarded for the inability to perform
the test or for the lack of a tested reflex; thus, the higher score,
the more severe the injury is [24].
For the adhesive-removal somatosensory test, somatosen-
sory deficit was measured both before and after surgery [25].
All rats were familiarized with the testing environment. In the
initial test, two small pieces of adhesive-backed paper dots (of
equal size, 113.1 mm2) were used as bilateral tactile stimuli
occupying the distal radial region on the wrist of each fore-
limb. The rat was then returned to its cage. The time to remove
each stimulus from forelimbs was recorded on five trials per
day. Individual trials were separated by at least 5 min. Before
surgery, the animals were trained for 3 days. Once the rats
were able to remove the dots within 10 s, they were subjected
to MCAO.
Microfil Perfusion and Micro-CT Scanning
Evaluation of angiogenesis using micro-CT was described
previously [26, 27]. In brief, after anesthesia, 100 mL of
heparinized saline and 20 mL of Microfil (Microfil MV-
122, Flow Tech; USA) were successively perfused into the
left ventricle with an angiocatheter. After Microfil perfu-
sion, the brains were scanned by micro-CT (SkyScan 1176,
Kontich, Belgium) at a resolution of 9 μm per voxel with a
1024 × 1024 pixel image matrix. For segmentation of
blood vessels from background, noise was removed by a
low-pass Gaussian filter. The blood vessels filled with
Microfil were included with semiautomatically drawn con-
tours at each two-dimensional section by the built-in
BContouring Program^ (SkyScan CTAn software) for au-
tomatic reconstruction of 3D images of vasculature. The
axial slices through the samples were then visualized.
The vessel volume in the ischemic area represented by
the voxels counted in the specified Microfil range was
calculated.
Immunofluorescence
Immunofluorescence staining was performed according to the
protocol previously described [28]. The primary antibodies
used were as follows: rabbit anti-RFP (1:200; Abcam Inc.,
USA), mouse ant i -PECAM-1 (1:50; Santa Cruz
Biotechnology, Germany), rabbit anti-Ki67 (1:200; Cell sig-
naling technology, USA). Each section was washed with PBS
and incubated with proper secondary antibodies at room tem-
perature for 2 h the following day. 1%BSA was used as a
control to confirm the specificity of the antibody and DAPI
(1:30) was used to detect the nucleus. Images were acquired
using a Leica fluorescence microscope (Leica, Germany).
Ki67+ /CD31+ microvessels in the perifocal region was count-
ed and quantified by an investigator who was blinded to the
experimental groups.
Cell Culture and Transfection
Human microvascular endothelial cells (HMEC-1) were cul-
tured in MCDB 131 medium (Gibco) containing 10% fetal
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bovine serum, L-glutamine (2 mM), epidermal growth factor
(10 ng/ml), and hydrocortisone (1 μg/ml) under standard con-
ditions (5% CO2, 37 °C, 95% humidity). HMEC-1 were seed-
ed into a 12-well plate at 5 × 104 cells and infected with
lentivirus at an MOI of 100. The expression of Meg3 in the
cells was determined by qPCR.
Cell Proliferation Assay
Transfected endothelial cells (1 × 104 cells/well) were seeded
into a 96-well plate and cultured for 1–7 days. At different
time points, the cell number was measured using a Cell-
Counting Kit-8 (CCK8) proliferation assay kit (Dojindo,
Japan). Briefly, cells were mixed with 10 μL of CCK-8
solution/well and incubated for 2 h at 37 °C; the amount of
formazan dye generated by cellular dehydrogenase activity
was thenmeasured by absorbance at 450 nmwith a microplate
reader. The optical density values of each well represented the
cell proliferation.
Cell Migration Assay
Transfected endothelial cells were plated into wells with culture
inserts (Ibidi, Germany) and incubated overnight. The next day,
the culture inserts were removed to leave a 500-μm scratched
wound, and the cell monolayer was rinsed once with
phosphate-buffered saline and cultured with or without
N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycinet-
butylester (DAPT). Pictures were taken of the wounds at 0- and
12-h time points using a Leica microscope at five distinct posi-
tions. WimScratch software (Ibidi, Germany) was used to de-
termine the migration distance as the reduction of the width of
the open area.
Tube Formation Assay
Tube formation was performed as previously described
[23, 29]. In brief, transfected endothelial cells (1 × 104)
were seeded in a 96-well plate coated with 100 μl of
growth factor-reduced Matrigel™ (BD, USA) and cultured
with culture medium in the presence or absence of DAPT.
Tube formation was quantified after 16 h by measuring the
total tube loops in five random microscopic fields with a
computer-assisted microscope (Leica, Germany).
Spheroid-Based Angiogenesis Assay
Endothelial cell spheroids of defined cell number were
generated as described previously [6, 30]. In brief,
transfected endothelial cells were suspended in culture
medium containing 0.20% (wt/vol) carboxymethylcellu-
lose (Sigma-Aldrich, USA) and seeded into non-adherent
round-bottom 96-well plates. Under these conditions, all
suspended cells contribute to the formation of a single
spheroid per well of defined size and cell number (400
cells/spheroid). Spheroids were generated overnight, after
which they were embedded into growth factor-reduced
Matrigel™ (BD, USA). The spheroid-containing gel was
rapidly transferred into prewarmed 96-well plates and
allowed to polymerize 30 min, then 100 μL of culture
medium with or without DAPT was added on top of the
gel. After 24 h, in vitro angiogenesis was quantified by
measuring the cumulative length of the sprouts or the
maximal distance of the migrated cells (Bsprout outgrowth
length^) that had grown out of each spheroid using digital
imaging microscope (Leica, Germany) analyzing ten
spheroids per group with WimSprout software.
Quantitative Real-Time PCR
Total RNA from brain tissues and cultured cells were isolated
using the Trizol reagent (Invitrogen, Life Technology, USA),
and 1 μg of total RNA from each sample was reverse-
transcribed into cDNA and subjected to quantitative real-
time PCR (qRT-PCR) using the SYBR Green I Kit (Roche)
according to the manufacturer’s protocol. The 2−ΔΔCt method
was used to calculate the relative expression of each gene
relative to the amount of β-actin or GAPDH. Primers used
for real-time PCR are summarized in Table S1.
Western Blot Analysis
Western blotting was performed as previously described
[23]. Briefly, equal amounts of protein were loaded onto
10% SDS-PAGE gels and blotted onto PVDF mem-
branes. Membranes were blocked with 4% non-fat milk and
incubated with primary antibodies against notch (1:1000, Cell
Signaling Technology, USA), Hes-1 (1:1000, Cell Signaling
Technology, USA), and Hey-1 (1:1000, LifeSpan
BioSciences, Inc., USA) overnight. β-actin (1:1000, Abcam
Inc., USA) was used as a loading control. After being washed,
the membranes were incubated with HRP-conjugated second-
ary antibodies for 2 h at room temperature. Specific binding
was detected with enhanced chemiluminescence reagents. The
blots were semiquantified by ImageJ analysis software for
comparisons.
Statistical Analysis
Parametric data from different groups were compared using
one-way ANOVA followed by the Student–Newman–Keuls
test. All data are presented as mean ± SD. Avalue of P < 0.05
was considered statistically significant.
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Meg3 Is Downregulated After Ischemic Stroke
We previously identified 1924 novel lncRNAs in rat brain using
Solexa sequencing (GSE78200). Using sequence homology
analysis, we noted that one of the novel lncRNAs was most
likely the ortholog of human andmouseMeg3. Cuffdiff results
revealed that there were 4 transcript variants and that
CUFF2.3 was the main transcript variant as calculated
by FPKM (Fig. 1a, b). To further validate this result, we
identified the 5′ and 3′ transcription start and termination
sites of the CUFF2.3 transcript by RACE analysis
(Fig. 1c), and the sequences of the full-length CUFF2.3
(which we termed rat Meg3 was located on rat chromo-
some 6, rn5 chr6:142,821,657–142,853,211) are presented
in Fig. S1. Meg3 is highly conserved between rat, mouse
(90.3% homology), and human (80.5% homology) ge-
nomes (Fig. S2).
To evaluate the function of this newly identified
lncRNA, the expression change of Meg3 over a period
of time was investigated. Ischemic stroke in rats caused
a decrease in Meg3 expression at day 1, a continuing
decline to the low-point level at day 3, and then a gradual
return to almost normal levels by 14 days after MCAO
(Fig. 1d). These results indicated that Meg3 was down-
regulated after MCAO.
Meg3 Knockdown Reduces Brain Lesions and Improves
Neurological Outcomes
To evaluate the effect of Meg3 on ischemic stroke, we first
performed Meg3 knockdown or overexpression in the rat
brains using a lentivirus vector. Immunofluorescence
showed that the RFP marker was stably expressed in the
brain 7 days after MCAO (Fig. 2a, b). PCR results showed
that rat injected with sh-Meg3 expressed low levels of
Meg3 (0.4-fold), and the rat injected with the Meg3
expressed high levels of Meg3 (4.1-fold) compared to the
control group 28 days post-MCAO (Fig. 2c).
Next, we examined whether Meg3 overexpression or
downregulation affected the outcome after focal ischemia.
TTC staining showed that the ischemic lesion volumes of
the four groups were 229.3 ± 14.9 mm3 (control group),
264.5 ± 10.5 mm3 (Meg3 group), 223.0 ± 8.4 mm3 (sh-
Ctrl group), and 174.7 ± 6.3 mm3 (sh-Meg3 group), re-
spectively (Fig. 3a, b). There were significant differences
in lesion volume among the control, Meg3, sh-Ctrl, and
sh-Meg3 groups, suggesting that Meg3 affected histolog-
ical outcome after focal ischemia.
We then determined whether Meg3 affected the neuro-
logical deficits after focal ischemia. Neurological out-
comes using mNSS and adhesive removal test were mea-
sured at 1–4 weeks after MCAO. Compared with the sh-Ctrl
group, the animals of the sh-Meg3 group exhibited significant
Fig. 1 Dynamic change of Meg3
after MCAO. a Four different rat
Meg3 isoforms were identified by
TopHat and Cufflinks. b Bar
graphs show the expression levels
of four different Meg3 isoforms. c
Agarose gel electrophoresis of
PCR products from the 5′-RACE
and 3′-RACE procedure (left).
Red lines indicate the
transcriptional start and end sites
(right). d Bar graphs show the
expression levels of Meg3 in the
ischemic penumbra at different
time points after MCAO
(n = 5/group). *P < 0.05 versus
sham controls
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functional enhancement in mNSS and adhesive-removal
maintaining time, while the Meg3 group exhibited
relatively poor performance in the mNSS and adhesive-
removal test 7 days after MCAO compared to the control
Fig. 2 Lentivirus-mediated
overexpression and knockdown
of Meg3 in rat brain. a Schematic
representation of the animal
experimental design. b Schematic
of lentivirus injection. Arrow
indicates the lentivirus injection
in the right striatum.
Immunofluorescence stains of
RFP distribution at day 7 after
MCAO. Scale bar = 100 μm. c
Bar graph shows the qRT-PCR
analysis of Meg3 expression
around the injection site 28 days
after MCAO (n = 5/group).
*P < 0.05 versus control,
#P < 0.05 versus sh-Ctrl,
&P < 0.05 versus Meg3
Fig. 3 Meg3 knockdown reduced brain infarct volumes and improved
neurobehavioral outcomes. a, b Representative images and bar graph
show the brain lesions in control, Meg3, sh-Ctrl, and sh-Meg3 groups
7 days post-MCAO (n = 5/group). c, d Bar graphs summarizing the result
of mNSS and adhesive removal test in control, Meg3, sh-Ctrl, and sh-
Meg3 groups at indicated times. *P < 0.05 versus control, #P < 0.05
versus sh-Ctrl, &P < 0.05 versus Meg3
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group (Fig. 3c, d). These data suggest that knockdown of
Meg3 significantly improved functional recovery after
stroke.
Meg3 Knockdown Promotes Angiogenesis After Ischemic
Stroke
Angiogenesis is a prerequisite for recovery from ischemic
stroke; hence, the formation of blood vessels was ana-
lyzed by micro-CT scanning. The 3D reconstructed im-
ages showed that a much higher microvessel density in
the Meg3 downregulated rats compared to the control
group, whereas in the Meg3-overexpressing rats, there
were less numbers of microvessels in the lenticulostriate
artery area 14 days post-MCAO (Fig. 4a). CD31 immu-
nofluorescence analysis further confirmed the results in
the peri-infarct area at 14 and 28 days after MCAO
(Fig. 4b). Dual-labeled immunofluorescence showed there
were more Ki67/CD31-positive cells in the sh-Meg3
group and less numbers of Ki67/CD31-positive cells in
the Meg3 group than in the control group (Fig. 4c).
These results suggest that Meg3 downregulation could
promote angiogenesis after focal ischemia.
Meg3 Regulates Endothelial Cell Function and Vessel
Growth In Vitro
To further explore the angiogenic functions of Meg3, we
constructed HMEC-1 cells with stable overexpression of
Meg3 (HMEC-Meg3) and stable downregulation of Meg3
(HMEC-sh-Meg3). qRT-PCR analysis showed that
lentiviral-mediated silencing of Meg3 resulted in a reduc-
tion of Meg3 (0.4-fold) in HMEC-sh-Meg3, and
lentiviral-mediated overexpression of Meg3 resulted in
upregulation of Meg3 (52.6-fold) in HMEC-Meg3 com-
pared to controls (Fig. 5a).
Proliferation, migration, and sprouting of endothelial
cells are crucial steps in angiogenesis. We further inves-
tigated the role of Meg3 in HMEC-1 cell function by
CCK-8, scratched wound, tube formation, and spheroid
Fig. 4 Meg3 knockdown promoted angiogenesis after ischemic stroke. a
Representative micro-CT images show the revascularization in control,
Meg3, sh-Ctrl, and sh-Meg3 groups 14 days post-MCAO. Bar graph
shows quantitative analysis of micro-CT vessel volume in each group.
b Representative images show CD31 staining at 14 and 28 days in
control, Meg3, sh-Ctrl, or sh-Meg3 groups. Bar = 100 μm. Bar graph
shows quantification of the microvessel density in each group (n = 5/
group). c Representative images show Ki67/CD31 staining in control,
Meg3, or sh-Meg3 groups 14 days post-MCAO. Bar = 50 μm. Bar
graph shows quantification of Ki67/CD31-poistive cells in the perifocal
region in each group (n = 5/group). *P < 0.05 versus control, #P < 0.05
versus sh-Ctrl, &P < 0.05 versus Meg3
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angiogenesis assays. Compared with HMEC-sh-Ctrl, si-
lencing of Meg3 increased endothelial cell proliferation
and migration. In contrast, overexpression of Meg3 pro-
foundly decreased endothelial cell proliferation and mi-
gration (Fig. 5b, c). Furthermore, compared with the
control group, HMEC-Meg3 rarely formed capillary-
like structures and sprouted fewer branch, whereas
HMEC-sh-Meg3 increased sprout length, the number
of branch points, and the number of sprouts per spher-
oid as indicated by tube formation and spheroid assays
(Fig. 5d, e).
Meg3 Knockdown Activates Notch Pathway
in Endothelial Cells and Ischemic Stroke
Notch signaling plays an important role in the regulation
of angiogenesis. To gain insights into the mechanism by
which Meg3 regulates angiogenesis, the expression
change of notch signaling in ischemia brains and endothe-
lial cells were performed. Western blot results also
showed that the protein level of NICD, Hes-1, and Hey1
in the ischemic brain was decreased in the Meg3 group
and increased in the sh-Meg3 group 7 days after MCAO
Fig. 5 Meg3 regulates endothelial cell function and vessel growth
in vitro. a Bar graph shows qRT-PCR analysis of Meg3 expression in
control, Meg3, sh-Ctrl, and sh-Meg3 HMEC-1. b Bar graph shows the
proliferation of control, Meg3, sh-Ctrl, and sh-Meg3 HMEC-1 over
7 days. c Representative images of control, Meg3, sh-Ctrl, and sh-Meg3
HMEC-1 migration. Bar graph shows the quantification of migration
distance. d Representative images of control, Meg3, sh-Ctrl, and sh-
Meg3 HMEC-1 spheroid sprouting. Bar graph shows the quantification
of cumulative sprout length per spheroid. e Representative images of
control, Meg3, sh-Ctrl, and sh-Meg3 HMEC-1 tube formation. Bar
graph shows the total loops of tube formation. *P < 0.05 versus control,
#P < 0.05 versus sh-Ctrl, &P < 0.05 versus Meg3
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compared to that in the control group (Fig. 6a, b).
Similarly, the expressions of NICD, Hes-1, and Hey-1
were decreased in HMEC-Meg3 and increased in
HMEC-sh-Meg3 (Fig. 6c, d). Taken together, these data
indicate that Meg3 activates the notch pathway in endo-
thelial cells and in ischemic stroke.
Notch Inhibition Impairs Meg3-Induced Angiogenic
Migration and Sprouting
Next, we determined whether the effect of Meg3 on endothe-
lial cells was mediated via the notch pathway. First, we used
the classical inhibitor DAPT to block the notch pathway.
Meg3 knockdown resulted in an increase of NICD in
HMEC-sh-Meg3, and the upregulation of NICDwas inhibited
by DAPT in a dose-dependent manner (Fig. S3). Based on
these data, 25 μM DAPT was selected for further studying
of angiogenic function. The cell motility, tube length, and
branch numbers in HMEC-sh-Meg3 were all significantly
higher than in the HMEC-sh-Ctrl. Blocking the notch pathway
was able to reverse the angiogenic activity induced by knock-
down of Meg3 as indicated by scratch assay, tube formation,
and spheroid assay (Fig. 7a–e). These results indicate that the
notch pathway could mediate the angiogenic effect of Meg3.
Discussion
Although the expression profile of lncRNAs has been shown
to change extensively after ischemia stroke [31] and growing
evidence in cerebral ischemia points to a multitude of
functions performed by lncRNA, including regulation of gene
expression and neuronal survival [22, 32, 33], the role of
lncRNAs in stroke is still largely unknown. Here, we identi-
fied a novel, previously unknown function of lncRNA-Meg3
which is downregulated after ischemic stroke and showed that
inhibition of Meg3 expression improves neurobehavioral out-
come and promotes angiogenesis both in vitro and in vivo.
Importantly, we also found that Meg3 acts as a regulator of
angiogenesis through activating the notch signaling pathway.
This study may provide a novel mechanism and potential
therapeutic target for ischemic stroke and angiogenesis-
related diseases.
In this study, rat Meg3 was identified by RNA se-
quencing. Sequence homology analysis revealed that
Meg3 is evolutionarily conserved between species, which
indicates Meg3 is functionally important. Meg3 was ini-
tially discovered as a tumor-associated lncRNA and was
reported to highly express in brain and endothelial cells
[6, 34, 35]. Zhang found that Meg3 is associated with
meningioma pathogenesis and meningioma loss of Meg3
expression has higher tumor grade [9]. Wang has reported
that Meg3 expression was markedly decreased in glioma
tissues and overexpression of the MEG3 could impair
glioma cell proliferation [12]. However, to date, the func-
tion of Meg3 in stroke has not been studied. Our data
showed that Meg3 knockdown significantly reduced in-
farct volume and improved neurological function recov-
ery, which was associated with increased functional
microvessels in the peri-infarct area as confirmed by
micro-CT and Ki67/CD31 double immunofluorescence.
The formation of new blood vessels via angiogenesis
Fig. 6 Meg3 regulates Notch
signaling. a Representative
Western blot of NICD, Hes-1, and
Hey-1 expression at 7 days after
MCAO. b Bar graph shows the
relative expression level of NICD,
Hes-1, and Hey-1 in control,
Meg3, sh-Ctrl, and sh-Meg3 rats
(n = 5/group). c Representative
Western blot of NICD, Hes-1, and
Hey-1 in control, Meg3, sh-Ctrl,
and sh-Meg3 HMEC-1. d Bar
graph shows the relative
expression of NICD, Hes-1, and
Hey-1. *P < 0.05 versus control,
#P < 0.05 versus sh-Ctrl,
&P < 0.05 versus Meg3
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contributes to the restoration of blood supply in the ische-
mic zone [3, 4]. Endothelial cell proliferation and migra-
tion and capillary tube-like structure formation are essen-
tial steps of angiogenesis [36]. We further demonstrated
that downregulation of Meg3 in endothelial cells result in
increased cell mobility, proliferation, and tube formation.
This angiogenesis effect of Meg3 was consistent with
previous findings, which showed that loss of Meg3 was
associated with brain blood vessel development in Meg3-
null embryos [14]. These findings suggest that Meg3
Fig. 7 Notch inhibition impairs Meg3-induced angiogenic migration and
sprouting. a sh-Ctrl and sh-Meg3 HMEC-1 were treated with or without
DAPT, and NICD was quantified by Western blotting after 24 h. b
Representative images of sh-Ctrl and sh-Meg3 HMEC-1 migration. Bar
graph shows quantification of the migration distance of cells treated with
or without DAPT. c Representative images of sh-Ctrl and sh-Meg3
HMEC-1 spheroid sprouts. Bar graph shows quantification of the
cumulative sprout length per spheroid with or without DAPT treatment.
d Representative images of sh-Ctrl and sh-Meg3 HMEC-1 tube
formation. Bar graph shows the total loops of tube formation treated
with or without DAPT. *P < 0.05 versus sh-Ctrl
Mol Neurobiol
participates in angiogenesis and vessel remodeling pro-
cess, which may contribute to long-term functional out-
come after ischemic brain injury.
Age is a principal risk factor for stroke. Previous stud-
ies showed that aged brain is capable of mounting a vig-
orous angiogenic response after stroke; however, the vast
majority of angiogenic response genes showed delayed
upregulation in the aged rats [37, 38]. The Notch pathway
is an ancient intercellular signaling mechanism, which is
fundamental for the development of human tissues, or-
gans, and systems. Current evidences have highlighted a
key role of Notch signaling in the pathophysiology of
age-related diseases, such as cardiovascular diseases and
Alzheimer’s disease [39]. In particular, Notch signaling is
activated in endothelial cells in response to ischemic stim-
uli [29]. Binding of notch receptors to ligands triggers the
activation of notch intracellular cytoplasmic domain
(NICD) which promotes the transcription of genes down-
stream (Hes-1 and Hey-1) in the Notch pathway. Previous
work showed that Notch signaling determines the forma-
tion of native arterial collateral networks in ischemic
stroke [40], and inhibition of Notch signaling impairs re-
parative angiogenesis after ischemia [41]. A number of
studies have reported that the increased expression of
Hes-1 plays an important role in angiogenesis [29, 42].
Notch1 and Hey-1/Hey-2 knockout mice do not express
the arterial endothelial markers in the remaining large ar-
teries [43]. In this study, we show that notch and notch
target genes (Hes-1 and Hey-1) were suppressed after
Meg3 overexpression and increased after Meg3 downreg-
ulation both in MCAO rats and in endothelial cells. In line
with previous articles, changes in the Notch signaling
pathway suggested that Meg3 may affect Notch
signaling-mediated angiogenesis after stroke. Functional
studies in mice, tumor models, and cell culture systems
have shown that the angiogenic growth of the blood ves-
sel network, the proliferation of endothelial cells, and the
regulation of blood vessel sprouting and branching are
controlled by Notch signaling [21, 44]. Activation of
Notch-1 in normal vasculature induces a proangiogenic
state [42]. Consistently, our data showed that Meg3
knockdown-induced endothelial cell proliferation, migra-
tion, and tube formation were reversed by notch inhibitor,
suggesting notch mediated the angiogenic effect of Meg3.
Taking together, our study indicates that Meg3 knock-
down may promote angiogenesis after ischemic brain in-
jury by activating the Notch signaling pathway.
Overall, this is the first study elucidating the function and
mechanism of Meg3 in angiogenesis after ischemic stroke.
Knockdown of Meg3 after stroke may thus promote angio-
genesis and functional recovery from stroke. Meg3 may also
be of therapeutic significance for promoting regeneration in
cases of ischemic vascular disease.
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